ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 151 filers reported holding ARGENX SE in Q4 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $988,000 | -53.8% | 3,589 | -50.6% | 0.00% | -50.0% |
| Q4 2020 | $2,138,000 | -28.7% | 7,271 | -36.3% | 0.01% | -33.3% |
| Q3 2020 | $2,997,000 | +2.4% | 11,416 | -12.2% | 0.01% | -10.0% |
| Q2 2020 | $2,928,000 | +38.9% | 13,000 | -18.8% | 0.01% | +100.0% |
| Q1 2020 | $2,108,000 | +54.5% | 16,000 | +88.2% | 0.01% | 0.0% |
| Q4 2019 | $1,364,000 | +21.4% | 8,500 | -5.6% | 0.01% | +25.0% |
| Q1 2019 | $1,124,000 | +34.8% | 9,000 | -18.2% | 0.00% | +33.3% |
| Q3 2018 | $834,000 | +234.9% | 11,000 | +266.7% | 0.00% | +200.0% |
| Q2 2018 | $249,000 | +54.7% | 3,000 | +50.0% | 0.00% | 0.0% |
| Q1 2018 | $161,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |